Pharmaceutical Investing Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
Medical Device Investing Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws
Pharmaceutical Investing BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China
LaFleur Minerals: Advancing a District-scale Gold Asset and Near-Producing Mill in the Abitibi Gold Belt